Stimulating excellence
At Neuromod, we collaborate with opinion-leading scientists and clinicians to conduct large-scale exploratory and confirmatory trials at internationally recognised clinical sites in order to build the evidence base for our interventions.
Neuromod's bimodal neuromodulation device, Lenire®, has been successful trialled across three large scale clinical trials involving 600+ participants. Trials were conducted at a number of European clinical sites under the guidance and supervision of our Science Advisory Board.
As a result of these trials, Lenire® has been granted a CE-mark in Europe and a FDA De Novo Grant in the United States for the treatment of tinnitus.
Details of clinical trials can be found here:
Phase I – Safety and Feasibility Study:
Download
Phase IIa (TENT-A1 Protocol Paper) – Parameter Optimisation and Patient Subtyping Study
Download
Phase IIa (TENT-A1 Results Paper) – Parameter Optimisation and Patient Subtyping Study
View
Phase IIb (TENT-A2 Protocol Paper) – Parameter Optimisation and Patient Subtyping Study
Download
Phase IIb (TENT-A2 Results Paper) – Parameter Optimisation and Patient Subtyping Study
View
Berthold Langguth is a Consultant Neuropsychiatrist who runs the Department of Psychiatry and Psychosomatic Medicine at Germany’s University of Regensburg Hospital (UHREG), which he has established as a leading European site for clinical trials and tinnitus research.
Prof. Langguth is an international key opinion leader in the field of tinnitus research with over 300 peer-reviewed publications and book chapters. A key focus area of research is patient subtyping and neuromodulation.
Prof. Langguth is the founder of the Tinnitus Research Initiative (TRI), a non-profit organisation that brings together tinnitus scientists from across the globe is dedicated to the development of effective treatments for all types of tinnitus.
Sven Vanneste is Professor of Neurosciences at Trinity College Dublin (TCD) in Ireland and the University of Texas at Dallas in the USA.
A leading voice in the field of neuromodulation research, with over 250 peer-reviewed publications and book chapters, Prof. Vanneste has established a neuromodulation research laboratory that has become a leading neuromodulation research centre globally.
Prof. Vanneste has collaborated on invasive and non-invasive neuromodulation trials for the Enterprise Ireland, the Health Research, Board, US Department of Defence (US-DoD), the US National Institutes for Health (NIH) and the US Food and Drug Administration (FDA) for neuromodulation start-ups and large medical device multinationals.
Deborah Hall is currently Head of the Department of Psychology at Heriot-Watt University Malaysia where she holds an appointment as Professor of Positive Psychology. Prior to this she led active tinnitus and translational neuroscience research teams at the University of Nottingham, UK and was Deputy Director of the National Institute for Health Research Nottingham Biomedical Research Centre.
In the fields of clinical trial methodologies and evidence-based medicines, Prof. Hall is highly regarded internationally, with over 100 peer-reviewed publications and book chapters. She was awarded the British Society of Audiology Thomas Simm Littler Prize in 2010 for her services to audiology, and is the Editor of ‘Hearing Research’, one of the highest impact factor journals in the world of auditory research.